BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23300559)

  • 1. Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients.
    Guo Y; Fan Y; Qiu J; Liu Y; Gao J; Guo F
    PLoS One; 2012; 7(12):e51723. PubMed ID: 23300559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.
    Guo YF; Qiu JX; Guo F; Liu Y; Shang MH
    Biomed Res Int; 2015; 2015():986780. PubMed ID: 25667935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients.
    Guo Y; Guo F; Wei C; Qiu J; Liu Y; Fang Y; Gao J
    PLoS One; 2013; 8(8):e70824. PubMed ID: 24015180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
    Guo Y; Gao J; Gao S; Shang M; Guo F
    Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.
    Misra MK; Pandey SK; Kapoor R; Sharma RK; Agrawal S
    Pharmacogenet Genomics; 2015 Jan; 25(1):19-29. PubMed ID: 25356901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in cytotoxic T lymphocyte associated antigen-4 influence the rate of acute rejection after renal transplantation in 167 Chinese recipients.
    Gao JW; Guo YF; Fan Y; Qiu JX; Bao ED; Liu Y; Qin Y; Zhang F
    Transpl Immunol; 2012 Jun; 26(4):207-11. PubMed ID: 22418270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.
    Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P
    Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study.
    Li Q; Wang B; Pan F; Zhang R; Xiao L; Guo H; Ma S; Zhou C
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1397-402. PubMed ID: 23432218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation.
    Bogacz A; Wolek M; Sieńko J; Czerny B; Machaliński B; Olbromski P; Kotowski M
    Sci Rep; 2021 Sep; 11(1):17531. PubMed ID: 34475433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.
    Joshita S; Umemura T; Yoshizawa K; Katsuyama Y; Tanaka E; Nakamura M; Ishibashi H; Ota M;
    J Hepatol; 2010 Sep; 53(3):537-41. PubMed ID: 20557968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of rs231775 (+49AG) CTLA4 gene polymorphism on transplanted kidney function.
    Domański L; Bobrek-Lesiakowska K; Kłoda K; Pawlik A; Safranow K; Wisniewska M; Romanowski M; Ciechanowski K
    Ann Transplant; 2012; 17(3):29-35. PubMed ID: 23018253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants.
    Canossi A; Aureli A; Delreno F; Iesari S; Cervelli C; Clemente K; Famulari A; Pisani F; Papola F
    Transplant Proc; 2013 Sep; 45(7):2645-9. PubMed ID: 24034013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.
    Sun L; Meng Y; Xie Y; Zhang H; Zhang Z; Wang X; Jiang B; Li W; Li Y; Yang Z
    PLoS One; 2014; 9(7):e101986. PubMed ID: 25003519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.
    Thude H; Schipler AD; Treszl A; Peine S; Koch M; Sterneck M; Nashan B
    Hum Immunol; 2013 Aug; 74(8):1041-5. PubMed ID: 23628397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
    Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients.
    Xin HW; Liu HM; Li YQ; Huang H; Zhang L; Yu AR; Wu XC
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):497-503. PubMed ID: 24691060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma.
    Tang W; Wang Y; Chen S; Lin J; Chen B; Yu S; Chen Y; Gu H; Kang M
    Scand J Immunol; 2016 Mar; 83(3):212-8. PubMed ID: 26709093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.